泌尿器科領域におけるPanfuran Sの使用経験
スポンサーリンク
概要
- 論文の詳細を見る
"Panfuran S" was administered to 50 patients with infectio ns who visited our clinic , 4 times a day (2 times a day for children) with a dose of 250 mg at each time. Effectiveness and side effects were carefully observed. The patients included 23 cases of acute cystitis, 7 cases of chronic cystitis, 5 cases of acute pyelonephritis, 2 cases of chronic pyelonephritis, 10 cases of prostatitis, and 3 cases of acute orchitis. The causal organisms in cystitis and pyelonephritis were mainly Gram-negative bacilli such as E. coli, Pseudomonas, Citrobacter, Klebsiella and Proteus, in which better sensitivity was demonstrated against "Panfuran S" than other antibiotics so far used . Streptococci showed similar sensitivity as Kanamycin, but Streptococci showed no sensitivity against "Panfuran S" Out of 13 patients with prostatitis and orchitis, 8 cases showed re c overy with the therapy, while the others who were infected by Streptococci showed no effect. These results indicated that "Panfuran S" is a satisfactory drug of c hoice for urinary tract infections due to Gram-negative bacilli and Staphylococci.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績